AzTrials
AzTrials

WoundNCT05601245

High Voltage Pulsed Current and Microcurrent Stimulation Therapy in Treatment of Wounds.

A study testing High voltage pulsed current and Microcurrent therapy in people with Wound and Ulcer, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the effectiveness of high-voltage pulsed current (HVPC) and microcurrent stimulation therapy (MST) in treating chronic wounds and to compare their effects. Read more about this study

Who is it for?
Ages 45 to 60 years
Conditions the study is for
Wound, Ulcer
What is being tested?
High voltage pulsed current and Microcurrent therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
10 Aug 2022to 20 Jul 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients are of both sexes.
  • Subject's age will be from 45 to 60 years.
  • All patients will enter the study having their informed consent.
  • All patients will be assessed by a physician before starting the study procedure.
  • All patients suffer from a chronic wound not healed more than or within six weeks.

Who cannot join

  • Patients with acute wounds.
  • Patients with burn wound injuries.
  • Malignancy in the wound.
  • Necrotic tissue in the wound.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Shaimaa Mohamed Ahmed Elsayeh

    Cairo, New Cairo, 02

Other trials in Egypt

About this study

Official title: High Voltage Pulsed Current Versus Microcurrent Stimulation Therapy in the Treatment of Chronic Wounds

The purpose of this study is to evaluate the effectiveness of high-voltage pulsed current (HVPC) and microcurrent stimulation therapy (MST) in treating chronic wounds and to compare their effects.

Read the detailed description

Sixty patients with chronic wounds (pressure ulcers) and their ages will be ranged from 45 to 60 years old. They will be recruited from the outpatient clinic at Kasr Al-Aini Hospitals and they will be randomly assigned into two groups of equal numbers, each one will contain thirty patients. High-voltage pulsed current group and microcurrent stimulation therapy groups. The change in wound surface area and wound volume will be measured before the intervention and after six weeks of intervention.

Conditions
Wound, Ulcer
Being tested
High voltage pulsed current, Microcurrent therapy
Keywords
High-voltage pulsed current, Micro-current therapy, Chronic wound
Medical subject headings
Wounds and Injuries, Ulcer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High voltage pulsed currentOther

    Also called Conventional physical therapy program

    The treatment session duration is 45 minutes (Reverse the polarity after the first 22 minutes)

  • Microcurrent therapyOther

    Also called Conventional physical therapy program

    The treatment session duration is 40 minutes.

Study groups in NCT05601245
Study groupRoleWhat they receive
High voltage pulsed currentExperimentalTwenty patients with chronic wounds will be managed by the high-voltage pulsed current for 45 as the total treatment duration and the polarity will be reversed after 22 minutes, three sessions per week for six weeks.
Receives: Other: High voltage pulsed current
Microcurrent therapyExperimentalTwenty patients with chronic wounds will be managed by microcurrent therapy for 40 minutes, three sessions per week for six weeks.
Receives: Other: Microcurrent therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in wound surface area

    A sterilized transparency film will be placed over the ulcer. The ulcer perimeter was traced by using the film tipped transparency marker. Each ulcer was traced three times to establish measurement reliability. After tracing, the side of the transparency film facing the ulcer will be cleaned with a piece of cotton and alcohol. Carbon paper was placed over the 1-mm-squared metric graph paper. The traced transparency film was placed over the carbon paper with white paper in between and the tracing will be transcribed onto the metric graph paper. WSA was calculated by counting the number of square millimeters on the metric graph within the wound tracing. The mean value of the three trials was calculated and taken to be the wound surface area.

    Measured: Baseline and six weeks after the intervention.

  2. Change in wound volume

    Assessment of wound volume was done by saline injection tool. A syringe of twenty cubic centimeters filled with normal sterilized saline was used. The patient was positioned in a comfortable position that allows the wound to be filled with the saline solution maximally. The saline was injected into each wound until its filling. The amount of saline injected was detected in cubic centimeters. These measurements were conducted for each patient before and after of treatment.

    Measured: Baseline and six weeks after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Nov 2022
  2. Study start10 Aug 2022
  3. Primary completion28 Apr 2023
  4. Study completion20 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Sixty patients (male and female) with chronic wounds (pressure ulcers) does not heal within six weeks were involved in the study. The diagnosis will be made clinically by the physician. The patients will be randomly assigned into two equal groups in number, two study groups (one for high-voltage pulsed galvanic current and the other for microcurrent therapy). Both groups will receive the same traditional physical therapy routine and conservative treatment for the wound for six weeks.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05601245
Sponsor's protocol ID
P.T.REC/012/003742
Status last verified
Mar 2024
First submitted
8 Oct 2022
Last updated
20 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing High voltage pulsed current and Microcurrent therapy in people with Wound and Ulcer, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in wound surface area (time frame: Baseline and six weeks after the intervention.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in